PROTECT MULTI AKTIENANLEIHE - BAYER/SANOFI/FRESENIUS Share Price

Certificat

DE000VU7QTR3

Market Closed - Deutsche Boerse AG 11:22:31 16/05/2024 pm IST
56.71 EUR -2.64% Intraday chart for PROTECT MULTI AKTIENANLEIHE - BAYER/SANOFI/FRESENIUS
Current month+4.17%
1 month+7.96%
Date Price Change
16/24/16 56.71 -2.64%
15/24/15 58.25 +0.40%
14/24/14 58.02 -0.48%
13/24/13 58.3 +1.57%
10/24/10 57.4 +1.13%

Delayed Quote Deutsche Boerse AG

Last update May 16, 2024 at 11:22 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VU7QTR
ISINDE000VU7QTR3
Date issued 12/06/2023
Strike 95.02
Maturity 21/06/2024 (35 Days)
Parity 0.1 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 103
Lowest since issue 51.93

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
89.17 EUR
Average target price
108.3 EUR
Spread / Average Target
+21.49%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW